The doors of precision: Reenergizing psychiatric drug development with psychedelics and open access computational tools.
Sci Adv March 16, 2022 Daniel S. Barron, Richard A. Friedman 5 citations
The text argues that combining psychedelic compounds with open-access computational tools could revitalize psychiatric drug development, which has stagnated. It proposes that precision medicine approaches, enabled by these tools, may allow for more targeted and effective treatments. The authors suggest this integration could overcome current limitations in the field, though no empirical data or results are presented.